Related Experiment Video
Updated: Aug 16, 2025
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Better Predictive Value of Lymphocyte Count and Hemoglobin for CD4 Level of HIV Patients
Zheng-Rong Gao1, Zheng Yuan1, Chang-Song Zhao1
1Department of Orthopaedics, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Chaoyang District, 100015, China.
Insights
Lymphocyte count and hemoglobin levels can predict CD4+ cell counts in HIV patients. This finding offers a valuable tool for monitoring disease progression and treatment effectiveness in individuals with HIV.
Area of Science:
- Immunology
- Hematology
- Infectious Diseases
Background:
- HIV infection leads to decreased CD4+ T cells, increasing susceptibility to opportunistic infections.
- Accurate monitoring of CD4+ T cell levels is crucial for managing HIV patients.
Purpose of the Study:
- To investigate the predictive value of lymphocyte count and hemoglobin levels for CD4+ T cell counts in HIV patients.
- To identify potential biomarkers for monitoring HIV progression.
Main Methods:
- Prospective study involving 125 HIV patients.
- Pearson chi-square test, univariate and multivariate logistic regression analyses were employed.
- Receiver Operating Characteristic (ROC) curves were constructed to assess diagnostic accuracy.
Main Results:
- Significant correlations were found between lymphocyte count, hemoglobin levels, and CD4+ T cell counts.
- Multivariate analysis confirmed lymphocyte count (OR=3.170) and hemoglobin (OR=2.545) as significant predictors of CD4+ levels.
- Identified high-risk warning indicators: 3 < lymphocyte (10^9/L) < 3.6 and 150 < hemoglobin (g/L) < 200.
Conclusions:
- Lymphocyte count and hemoglobin levels demonstrate significant predictive value for CD4+ T cell counts in HIV patients.
- These parameters can serve as accessible indicators for monitoring CD4+ levels and guiding clinical management.
Objective:
HIV patients are prone to infection and difficult to treat, which mainly manifests itself in decreased CD4+ T cells in the body. Therefore, the predictive value of lymphocyte count and hemoglobin for CD4+ levels in HIV patients was discussed in the prospective study.
Methods:
125 HIV patients (aged >18 or < 80 years) were recruited. Pearson chi-square test was used to explore the correlation between CD4+ content and blood-related parameters in HIV patients. Univariate and multivariate logistic regression analyses were used to calculate ORs for each variable. In addition, receiver ROC curves were constructed to assess each factor's accuracy and sensitivity in diagnosing CD4+.
Results:
Lymphocyte count and hemoglobin were significantly correlated with CD4+. In terms of multivariate logistic regression level, there was a significant correlation between lymphocyte count (OR = 3.170, 95% CI: 1.442-6.969, P = 0.004), hemoglobin (OR = 2.545, 95% CI: 1.148- 5.646, P = 0.022) and CD4+ content in HIV patients. Based on the neural network model, the level of lymphocyte and hemoglobin might be the predictive indexes of CD4+ level. We find the high-risk warning indicator of CD4+ level: 3 < lymphocyte (109/L) < 3.6, and 150 < hemoglobin (g/L) < 200.
Conclusion:
Better predictive value of lymphocyte count and hemoglobin for CD4+ level of HIV patients.
